Compound information
- Natural Products
- ZC924375
- Molecular Formula
- C17H24N2O3S
- Molecular Weight
- 336.150763628 g/mol
- Structure
-
- IUPAC Name
- cyclopropyl-[4-(4-isopropylphenyl)sulfonylpiperazin-1-yl]methanone
- InChI
- InChI=1S/C17H24N2O3S/c1-13(2)14-5-7-16(8-6-14)23(21,22)19-11-9-18(10-12-19)17(20)15-3-4-15/h5-8,13,15H,3-4,9-12H2,1-2H3
- InChI Key
- CNAAGPCCSRLYAY-UHFFFAOYSA-N
- SMILES
- CC(C)c1ccc(S(=O)(=O)N2CCN(C(=O)C3CC3)CC2)cc1
- Source
- ZINC000012383060
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 57.69 Å2 | LogP | 2.36 |
LogS | -3.512 | LogD | 2.676 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.028 | Pgp substrate | 0.985 |
HIA | 0.967 | F20 % | 0.994 |
F30 % | 0.913 | Caco-2 | -4.419 |
MDCK | -4.818 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.64 | PPB | 94.157 |
VD | 0.506 | Fu | 0.764 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.013 | CYP1A2 substrate | 0.387 |
CYP2A6 substrate | 0.44 | CYP2B6 substrate | 0.649 |
CYP2C19 inhibitor | 0.647 | CYP2C19 substrate | 0.718 |
CYP2C8 substrate | 0.575 | CYP2C9 inhibitor | 0.251 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.064 |
CYP2D6 substrate | 0.591 | CYP2E1 substrate | 0.245 |
CYP3A4 inhibitor | 0.239 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.127 | CL | 6.176 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.851 | Hepatotoxicity | 0.631 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.192 |
FDAMDD | 0.389 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.902 | Eye Corrosion | 0.006 |
Eye Irritation | 0.018 | Respiratory Toxicity | 0.043 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.517 | IGC50 | 3.14 |
LC50FM | -2.182 | LC50DM | 3.579 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.207 | NR-AR-LBD | 0.29 |
NR-AhR | 0.042 | NR-Aromatase | 0.545 |
NR-ER | 0.263 | NR-ER-LBD | 0.362 |
NR-PPAR-gamma | 0.153 | SR-ARE | 0.631 |
SR-ATAD5 | 0.311 | SR-HSE | 0.094 |
SR-MMP | 0.015 | SR-p53 | 0.031 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.